Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: Association with tumor progression

Journal of Urology

Volumn 155, Issue 1, 1996, Pages 316-320

  King, Edward D ^b   Matteson, James ^b   Jacobs, Stephen C ^b   Kyprianou, Natasha ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Apoptosis; Carcinoma, transitional cell; Transforming growth factor beta

Indexed keywords

MONOCLONAL ANTIBODY; ONCOPROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTO ONCOGENE; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH; UROTHELIUM;

APOPTOSIS; BLADDER; BLADDER NEOPLASMS; CARCINOMA, TRANSITIONAL CELL; CELL DIVISION; DISEASE-FREE SURVIVAL; GENE EXPRESSION; GTP-BINDING PROTEINS; HUMAN; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029655696     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66652-7     Document Type: Article

References (28)

1. Boring, C. C., Squires, T. S., Tong, T. and Montgomery, S.: Cancer statistics, 1994. C. A. Cancer J. Clin., 44: 7, 1994.
2. Catalona, W. J.: Urothelial tumors of the urinary tract. In: Campbell's Urology Edited by P. C. Walsh, A. B. Retik, T. A. Stamey and E. D. Vaughn, Jr. Philadelphia: W. B. Saunders, pp. 1094-1158, 1992.
3. Fontana, D., Bellina, M., Gubetta, L., Fasolis, G., Rolle, L., Scoffone, C., Porpiglia, F., Colombo, M., Tarabuzzi, R. and Leonardo, E.: Monoclonal antibody Ki-67 in the study of the proliferative activity of bladder carcinoma. J. Urol., 148: 1149, 1992.
4. Cohen, M. B., Waldman, F. M., Carroll, P. R., Kerschmann, R., Chew, K. and Mayall, B. H.: Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder. Human Pathol., 24: 772, 1993.
5. Stewart, B. W.: Mechanism of apoptosis: integration of genetic, biochemical, and cellular indicators. J. Natl. Cancer Inst., 86: 1286, 1994.
6. Reed, J. C.: Bcl-2 and the regulation of programmed cell death. J. Cell Biol., 124: 1, 1994.
7. Vaux, D., Cory, S. and Adams, J.: Bcl-2 gene promotes haematopoetic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature, 355: 440, 1988.
8. Allsopp, T. E., Wyatt, S., Paterson, H. F. and Davies, A. M.: The protooncogene bcl-2 can selectively rescue neurotropic factor-dependent neurons from apoptosis. Cell, 73: 295, 1993.
9. Walton, M. I., Whysong, D., O'Connor, P. M., Hockenbery, D., Korsmeyer, S. J. and Kohn, K. W.: Constitutive expression of human bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res., 53: 1853, 1993.
10. Bhargava, V., Kell, D. L., Van de Rijn, M. and Warnke, R. A.: Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am. J. Pathol., 145: 535, 1994.
11. Joensuu, H., Pylkkanen, L. and Toikkanen, S.: Bcl-2 protein expression and long-term survival in breast cancer. Am. J. Pathol., 145: 1191, 1994.
12. McDonnell, T. J., Troncoso, P., Brisbay, S. M., Logothetis, C., Chung, L. W. K., Hsieh, J., Tu, S. and Campbell, M. L.: Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res., 52: 6940, 1992.
13. Charlotte, F., L'Hermine, A., Martin, N., Geleyn, Y., Nollet, M., Gaulard, P. and Zafrani, E.S.: Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am. J. Pathol., 144: 460, 1994.
14. Pezzella, F., Turley, H., Kuzu, I., Tungekar, M. F., Dunhill, M. S., Pierce, C. B., Harris, A., Gatter, K. C. and Mason, D. Y.: Bcl-2 protein in non-small cell lung carcinoma. N. Engl. J. Med., 329: 690, 1993.
15. Massague, J.: The transforming growth factor-β family. Annu. Rev. Cell Biol., 6: 597, 1990.
16. Taetle, R., Payne, C., Dos Santos, B., Russell, M. and Segarini, P.: Effects of transforming growth factor β-1 on growth and apoptosis of human acute myelogenous leukemia cells. Cancer Res., 53: 3386, 1993.
17. Rotello, R. J., Lieberman, R. C., Purchio, A. F. and Gerschenson, L. E.: Coordinated regulation of apoptosis and cell proliferation by transforming growth factor β1 in cultured uterine epithelial cells. Proc. Natl. Acad. Sci. U.S.A., 88: 3412, 1991.
18. Yanagihara, K. and Tsumuraya, M.: Transforming growth factor β1 induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res., 52: 4042, 1992.
19. Kyprianou, N. and Isaacs, J. T.: Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death. Mol. Endocrinol., 3: 1515, 1989.
20. Thiery, M.: Highly sensitive immunodetection of DNA on sections with endogenous terminal deoxynucleotidyl transferase and non-isotopic nucleotide analogues. J. Histochem. Cytochem., 40: 411, 1992.
21. Flanders, K. C., Thompson, N. L., Cissel, D. S., Van Obberghen-Schilling, E., Baker, C. L., Kass, M. E., Ellingsworth, L. R., Roberts, A. B. and Sporn, M. B.: Transforming growth factor β-1: histochemical localization with antibodies to different epitopes. J. Cell Biol., 108: 653, 1989.
22. Sarraf, C. E. and Bowen, I. D.: Kinetic studies on a murine sarcoma and an analysis of apoptosis. Br. J. Cancer, 54: 989, 1986.
23. Tsujihashi, H., Nakanishi, A., Matsuda, H., Uejima, S. and Kurita, T.: Cell proliferation of human bladder tumors determined by BRDURD and KI-67 immunostaining. J. Urol., 145: 846, 1991.
24. Mulder, A. H., Van Hootegem, J. C. S. P., Sylvester, R., Ten Kate, F. J. W., Kurth, K. H., Ooms, E. C. M. and Van Der Kwast, T. H.: Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67). J. Pathol., 166: 37, 1992.
25. Okamura, K., Miyake, K., Koshikawa, T. and Asai, J.: Growth fractions of transitional cell carcinoma of the bladder defined by the monoclonal antibody KI-67. J. Urol., 144: 875, 1990.
26. Bush, C., Norton, J., Parkins, C. S., Bailey, M. J., Boyd, M. J., Jones, C. R., A'Hern, R. P. and Horwich, A.: Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importance. Br. J. Cancer, 64: 357, 1991.
27. Coombs, L. M., Pigott, D. A., Eydmann, M. E., Proctor, A. J. and Knowles, M. A.: Reduced expression of TGF-β is associated with advanced disease in transitional carcinoma. Br. J. Cancer, 67: 578, 1993.
28. deBoer, W. I., Schuller, A. G. P., Vermy, M. and van der Kwast, T. H.: Expression of growth factors and receptors during specific phases in regenerating urothelium after acute injury in vivo. Am. J. Pathol., 145: 1199, 1994.